Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on December 2, 2016. The report addresses the fulfillment of the "Long Term Investor Right" (LTIR) associated with the company's initial public offering (IPO) which closed on November 24, 2014.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity event.
Material Changes
The material event reported is the issuance of supplemental common stock to qualifying IPO holders. An independent CPA firm, Windes, calculated that an aggregate of 341,799 shares are issuable to qualified purchasers. These shares are issued at no additional cost to holders who registered their shares in their own name (not street name) within 90 days of the IPO and continuously held them for two years.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general business risks. The only contingency mentioned is the strict adherence to the holding period and registration requirements necessary to qualify for the LTIR shares.
Investor Verification Checklist
- Verify the registrant name is Second Sight Medical Products, Inc., not Vivani Medical, Inc.
- Confirm the total number of supplemental shares issued is 341,799.
- Review the attached Windes Report (Exhibit 99.1) for the specific allocation formula and individual holder details.
- Note that this filing does not contain financial performance data for the period.